[go: up one dir, main page]

PE20030136A1 - BIOADHESIVE TABLETS FOR PROGRESSIVE HYDRATION - Google Patents

BIOADHESIVE TABLETS FOR PROGRESSIVE HYDRATION

Info

Publication number
PE20030136A1
PE20030136A1 PE2001000582A PE2001000582A PE20030136A1 PE 20030136 A1 PE20030136 A1 PE 20030136A1 PE 2001000582 A PE2001000582 A PE 2001000582A PE 2001000582 A PE2001000582 A PE 2001000582A PE 20030136 A1 PE20030136 A1 PE 20030136A1
Authority
PE
Peru
Prior art keywords
water
progressive hydration
polymer
composition
sponged
Prior art date
Application number
PE2001000582A
Other languages
Spanish (es)
Inventor
William J Bologna
Howard L Levine
Ziegler Dominique De
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/877,218 external-priority patent/US6624200B2/en
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of PE20030136A1 publication Critical patent/PE20030136A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA BIOADHESIVA PARA HIDRATACION PROGRESIVA QUE COMPRENDE: a) UNA CANTIDAD EFECTIVA DE TESTOSTERONA; b) UN POLIMERO POLICARBOXILICO INSOLUBLE, DEGRADABLE QUE SE PUEDE ESPONJAR CON AGUA COMO POLICARBOFIL; c) UN POLIMERO HIDROSOLUBLE (CARBOMERO 974P) . LA TESTOSTERONA ESTA PRESENTE EN 30 mg POR DOSIS UNITARIA DE LA COMPOSICION. SE REFIERE TAMBIEN A UNA COMPOSICION QUE COMPRENDE TERBUTALINA, UN POLIMERO POLICARBOXILICO INSOLUBLE DEGRADABLE QUE SE PUEDE ESPONJAR CON AGUA Y UN POLIMERO HIDROSOLUBLEIT REFERS TO A BIOADHESIVE PHARMACEUTICAL COMPOSITION FOR PROGRESSIVE HYDRATION INCLUDING: a) AN EFFECTIVE AMOUNT OF TESTOSTERONE; b) AN INSOLUBLE, DEGRADABLE POLYCARBOXYL POLYMER THAT CAN BE SPONGED WITH WATER AS POLYCARBOFIL; c) A WATER-SOLUBLE POLYMER (CARBOMER 974P). TESTOSTERONE IS PRESENT IN 30 mg PER UNIT DOSE OF THE COMPOSITION. IT ALSO REFERS TO A COMPOSITION INCLUDING TERBUTALIN, A DEGRADABLE INSOLUBLE POLYCARBOXYL POLYMER THAT CAN BE SPONGED WITH WATER AND A WATER-SOLUBLE POLYMER

PE2001000582A 2000-06-16 2001-06-15 BIOADHESIVE TABLETS FOR PROGRESSIVE HYDRATION PE20030136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59607300A 2000-06-16 2000-06-16
US09/877,218 US6624200B2 (en) 1998-08-25 2001-06-11 Bioadhesive progressive hydration tablets

Publications (1)

Publication Number Publication Date
PE20030136A1 true PE20030136A1 (en) 2003-03-18

Family

ID=24385886

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000582A PE20030136A1 (en) 2000-06-16 2001-06-15 BIOADHESIVE TABLETS FOR PROGRESSIVE HYDRATION

Country Status (4)

Country Link
CO (1) CO5270003A1 (en)
PE (1) PE20030136A1 (en)
TW (2) TWI311916B (en)
ZA (1) ZA200104935B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI554708B (en) 2015-11-11 2016-10-21 宣明智 Affixation Element for Micro Devices and Micro Devices

Also Published As

Publication number Publication date
TWI311916B (en) 2009-07-11
TWI319987B (en) 2010-02-01
ZA200104935B (en) 2002-12-11
CO5270003A1 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
AR032352A1 (en) BIOADHESIVE PHARMACEUTICAL COMPOSITION OF GRADUAL HYDRATION AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE ADMINISTRATION OF TESTOSTERONE AND TERBUTALINE TO A MAMMER THROUGH A MUCOSA SURFACE.
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
CO5261517A1 (en) ANALGESIC PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORFINE / NALOXONE, BUPRENORFINE / NALTREXONE OR BUPRENORPHINE / NALMEFEN IN LOW DOSE
ES2128369T3 (en) PROCEDURE FOR THE MANUFACTURE OF SOLID PHARMACEUTICAL FORMS WITH PROLONGED RELEASE IN TWO STAGES.
PA8509001A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
ES2178876T3 (en) FAST DISINTEGRATION PADS.
PE20050775A1 (en) FORMULATIONS THAT INCLUDE CONTROLLED RELEASE MULTI-PARTICLES
DOP2001000241A (en) SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS
AR028299A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
TW200633730A (en) Oral disintegrating dosage forms
PA8562201A1 (en) DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS
PE20010952A1 (en) COMPOSITION FOR ORAL EXTENDED RELEASE DOSE
CO5190688A1 (en) PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A 100 MG / ML HYDROSOLUBILITY, AND PROCEDURES FOR PREPARATION
ES2177346T3 (en) SLOW RELEASE RANOLAZINE FORMULATIONS.
CA2716874A1 (en) A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
ES2111547T3 (en) PROLONGED RELEASE TABLET.
CO5251434A1 (en) COMPOSITION OF CONTROLLED RELEASE
BR0307278A (en) Immediate release oral formulation and method for preparing a formulation
CO5540295A2 (en) COMPRESSED TO GET THAT PARACETAMOL UNDERSTANDS
ES2099021B1 (en) PHARMACEUTICAL COMPOSITION THAT HAS ANALGESIC ACTIVITY.
PE20030136A1 (en) BIOADHESIVE TABLETS FOR PROGRESSIVE HYDRATION
AR052322A1 (en) N-BENZOIL-ESTAUROSPORINE COMPOUNDS, PROCESSES FOR PREPARATION AND PHARMACEUTICAL COMPOSITION
AR026010A1 (en) ORAL DOSING UNIT ORALALLY DISARNING CONTAINING THE MIRTAZAPINE ANTIDEPRESSIVE AS ACTIVE INGREDIENT
DE602004014964D1 (en) PHARMACEUTICAL COMPOSITION WITH A CATIONIC AGENT
ATE163265T1 (en) ASSOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRONE DERIVATIVES AND CALCIUM SALTS

Legal Events

Date Code Title Description
FC Refusal